Remove keyword evusheld
article thumbnail

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Rethinking Clinical Trials

When Evusheld was approved in December 2021 a similar weighted lottery process was put into place. UPMC built upon the success of the Remdesivir lottery and in December 2020, UPMC began infusing monoclonal antibodies across 45 UPMC locations. Clinicians wrote a consult for mABs and the pharmacy delivered whichever mAB that was available.